1. Home
  2. QSI vs PCRX Comparison

QSI vs PCRX Comparison

Compare QSI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

N/A

Current Price

$0.85

Market Cap

273.7M

Sector

Health Care

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

N/A

Current Price

$23.16

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QSI
PCRX
Founded
2013
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.7M
1.0B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
QSI
PCRX
Price
$0.85
$23.16
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$1.00
$37.60
AVG Volume (30 Days)
2.7M
801.0K
Earning Date
03-03-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.16
Revenue
N/A
$541,533,000.00
Revenue This Year
$196.35
$9.77
Revenue Next Year
$229.03
$9.71
P/E Ratio
N/A
$138.44
Revenue Growth
N/A
26.04
52 Week Low
$0.83
$18.80
52 Week High
$3.10
$27.99

Technical Indicators

Market Signals
Indicator
QSI
PCRX
Relative Strength Index (RSI) 39.20 55.01
Support Level N/A $22.57
Resistance Level $1.11 $23.91
Average True Range (ATR) 0.06 0.98
MACD -0.00 -0.01
Stochastic Oscillator 19.03 67.69

Price Performance

Historical Comparison
QSI
PCRX

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: